Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
format_facet:"Aufsätze"
topic_facet:"610"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22610%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=8
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22610%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=8
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22610%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=8
PubPharm (8.942)
71
FFA115283: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED (WHIT RESCUE MEDICATION), MULTI-CENTRE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INHALED FLUTICASONE FUROATE IN THE TREATMENT OF PERSISTENT ASTHMA IN ADULTS AND ADOLESCENTS NOT CURRENTLY RECEIVING INHALED CORTICOSTEROIDS : FFA115283: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED (WHIT RESCUE MEDICATION), MULTI-CENTRE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INHALED FLUTICASONE FUROATE IN THE TREATMENT OF PERSISTENT ASTHMA IN ADULTS AND ADOLESCENTS NOT CURRENTLY RECEIVING INHALED CORTICOSTEROIDS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
72
NO DISPONIBLE : A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP, PLACEBO CONTROLLED (ON INHALED CORTICOSTEROID MEDICATION), MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF VILANTEROL INHALATION POWDER (GW642444) AND SALMETEROL, COMPARED WITH PLACEBO IN THE TREATMENT OF PERSISTENT ASTHMA EN ADULTOS Y ADOLESCENTES NO CONTROLADOS CON CORTICOSTEROIDES INHALADOS.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
73
RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL TO STUDY THE EFFICACY AND SAFETY OF A MONTELUKAST INHALED CORTICOSTEROID COMPARED TO THERAPY WITH A INHALED CORTICOSTEROID ONLY, IN PATIENTS WITH CHRONIC ASTHMA : RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL TO STUDY THE EFFICACY AND SAFETY OF A MONTELUKAST INHALED CORTICOSTEROID COMPARED TO THERAPY WITH A INHALED CORTICOSTEROID ONLY, IN PATIENTS WITH CHRONIC ASTHMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
74
A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF LEBRIKIZUMAB IN ADOLESCENT PATIENTS WITH UNCONTROLLED ASTHMA WHO ARE ON INHALED CORTICOSTEROIDS AND A SECOND CONTROLLER MEDICATION : A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF LEBRIKIZUMAB IN ADOLESCENT PATIENTS WITH UNCONTROLLED ASTHMA WHO ARE ON INHALED CORTICOSTEROIDS AND A SECOND CONTROLLER MEDICATION
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
75
A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF LEBRIKIZUMAB IN PATIENTS WITH UNCONTROLLED ASTHMA WHO ARE ON INHALED CORTICOSTEROIDS AND A SECOND CONTROLLER MEDICATI : A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF LEBRIKIZUMAB IN PATIENTS WITH UNCONTROLLED ASTHMA WHO ARE ON INHALED CORTICOSTEROIDS AND A SECOND CONTROLLER MEDICATI
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
76
A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED, PHASE 3 EFFICACY AND SAFETY STUDY OF BENRALIZUMAB (MEDI-563) ADDED TO MEDIUM-DOSE INHALED CORTICOSTEROID PLUS LONG-ACTING β2 AGONIST IN PATIENTS WITH UNCONTROLLED ASTHMA (PAMPERO) : A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED, PHASE 3 EFFICACY AND SAFETY STUDY OF BENRALIZUMAB (MEDI-563) ADDED TO MEDIUM-DOSE INHALED CORTICOSTEROID PLUS LONG-ACTING β2 AGONIST IN PATIENTS WITH UNCONTROLLED ASTHMA (PAMPERO)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
77
A RANDOMIZED, DOUBLED-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED MULTI-CENTRE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FLUTICASONE FUROATE INHALATION POWDER AND FLUTICASONE PROPIONATE INHAATION POWDER IN THE TREATMENT OF ASTHMA IN ADULTS AND ADOLESCENTS NOT CURRENTLY TREATED WITH INHALED CORTICOSTEROIDS : A RANDOMIZED, DOUBLED-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED MULTI-CENTRE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FLUTICASONE FUROATE INHALATION POWDER AND FLUTICASONE PROPIONATE INHAATION POWDER IN THE TREATMENT OF ASTHMA IN ADULTS AND ADOLESCENTS NOT CURRENTLY TREATED WITH INHALED CORTICOSTEROIDS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
78
A DOSE-RANGING STUDY OF VILANTEROL (VI) INHALATION POWDER IN CHILDREN AGED 5-11 YEARS WITH ASTHMA ON A BACKGROUND OF INHALED CORTICOSTEROID THERAPY : A DOSE-RANGING STUDY OF VILANTEROL (VI) INHALATION POWDER IN CHILDREN AGED 5-11 YEARS WITH ASTHMA ON A BACKGROUND OF INHALED CORTICOSTEROID THERAPY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
79
RANDOMIZED STUDY OF STAGE THALIDOMIDE (NSC 66847) MORE DEXAMETHASONE, VERSUS DEXAMETHASONE IN PATIENTS WITH RECENT DIAGNOSIS OF MULTIPLE MYELOMA. : RANDOMIZED STUDY OF STAGE THALIDOMIDE (NSC 66847) MORE DEXAMETHASONE, VERSUS DEXAMETHASONE IN PATIENTS WITH RECENT DIAGNOSIS OF MULTIPLE MYELOMA.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
80
A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED, PHASE III EFFICACY AND SAFETY STUDY OF BENRALIZUMAB (MEDI-563) ADDED TO HIGH-DOSE INHALED CORTICOSTEROID PLUS LONG-ACTING β2 AGONIST IN PATIENTS WITH UNCONTROLLED ASTHMA (SIROCCO) : A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED, PHASE III EFFICACY AND SAFETY STUDY OF BENRALIZUMAB (MEDI-563) ADDED TO HIGH-DOSE INHALED CORTICOSTEROID PLUS LONG-ACTING β2 AGONIST IN PATIENTS WITH UNCONTROLLED ASTHMA (SIROCCO)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
[1]
« Vorheriger
3
4
5
6
7
8
9
10
11
12
13
Nächster »
[895]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Medienart: Aufsätze
Filter aufheben
Thema: 610
Medienart
Aufsätze
8.942
E-Artikel
8.942
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
610
8.620
Study Type: Interventional
3.992
Recruitment Status: Not yet recruiting
2.142
Phase: Phase 3
1.648
Recruitment Status: Completed
1.434
Recruitment Status: Authorised-recruitment may ...
1.262
Recruitment Status: Recruiting
1.210
Phase: Phase 2
618
Phase: Phase 4
284
Phase: Phase 2/Phase 3
268
Recruitment Status: Complete: follow-up complete
266
Study Type: Observational
240
Phase: Phase 1
174
Medical Condition: Health Condition 1: O- Medic...
134
Medical Condition: Multiple Myeloma MedDRA vers...
84
Phase: Other
82
Medical Condition: Multiple Myeloma
58
Medical Condition: Asthma MedDRA version: 18.1L...
56
Medical Condition: Asthma MedDRA version: 20.0L...
56
Medical Condition: Multiple myeloma MedDRA vers...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5.178
2020-
3.764
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8.770
Englisch
122
Unbestimmt
26
Spanisch
12
Französisch
4
Dänisch
4
Deutsch
2
Tschechisch
2
Niederländisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...